Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real−world retrospective study

OBJECTIVES: The treatment of locally advanced oral or oropharyngeal squamous cell carcinoma (LAOOPSCC) is surgery and radiotherapy or chemoradiotherapy but with unsatisfactory survival rate. Neoadjuvant programmed death-1 (PD-1) therapy are being used in several clinical trials. Therefore, in this r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wen-Jie, Liu, Qian, An, Pu-Gen, Wang, Lin, Zhang, Jian-Yun, Chen, Yan, Zhang, Tong, Zhang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685444/
https://www.ncbi.nlm.nih.gov/pubmed/38035079
http://dx.doi.org/10.3389/fimmu.2023.1282629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685444/
https://www.ncbi.nlm.nih.gov/pubmed/38035079
http://dx.doi.org/10.3389/fimmu.2023.1282629

Ejemplares similares